Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 1
2017 2
2018 2
2021 4
2022 2
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B2 receptor antagonism.
Jakwerth CA, Feuerherd M, Guerth FM, Oelsner M, Schellhammer L, Giglberger J, Pechtold L, Jerin C, Kugler L, Mogler C, Haller B, Erb A, Wollenberg B, Spinner CD, Buch T, Protzer U, Schmidt-Weber CB, Zissler UM, Chaker AM. Jakwerth CA, et al. Among authors: guerth fm. J Mol Med (Berl). 2022 Apr;100(4):613-627. doi: 10.1007/s00109-022-02182-7. Epub 2022 Mar 5. J Mol Med (Berl). 2022. PMID: 35247068 Free PMC article.
TGF-β1 Drives Inflammatory Th Cell But Not Treg Cell Compartment Upon Allergen Exposure.
Musiol S, Alessandrini F, Jakwerth CA, Chaker AM, Schneider E, Guerth F, Schnautz B, Grosch J, Ghiordanescu I, Ullmann JT, Kau J, Plaschke M, Haak S, Buch T, Schmidt-Weber CB, Zissler UM. Musiol S, et al. Among authors: guerth f. Front Immunol. 2022 Jan 7;12:763243. doi: 10.3389/fimmu.2021.763243. eCollection 2021. Front Immunol. 2022. PMID: 35069535 Free PMC article.
Sputum microRNA-screening reveals Prostaglandin EP3 receptor as selective target in allergen-specific immunotherapy.
Jakwerth CA, Chaker AM, Guerth F, Oelsner M, Pechtold L, Zur Bonsen LS, Ullmann JT, Krauss-Etschmann S, Erb A, Kau J, Plaschke M, Winkler M, Kurz A, Kloss A, Esser-von Bieren J, Schmidt-Weber CB, Zissler UM. Jakwerth CA, et al. Among authors: guerth f. Clin Exp Allergy. 2021 Dec;51(12):1577-1591. doi: 10.1111/cea.14013. Epub 2021 Sep 22. Clin Exp Allergy. 2021. PMID: 34514658
Biomatrix for upper and lower airway biomarkers in patients with allergic asthma.
Zissler UM, Ulrich M, Jakwerth CA, Rothkirch S, Guerth F, Weckmann M, Schiemann M, Haller B, Schmidt-Weber CB, Chaker AM. Zissler UM, et al. Among authors: guerth f. J Allergy Clin Immunol. 2018 Dec;142(6):1980-1983. doi: 10.1016/j.jaci.2018.07.027. Epub 2018 Aug 16. J Allergy Clin Immunol. 2018. PMID: 30121290 No abstract available.
Interleukin-4 and interferon-γ orchestrate an epithelial polarization in the airways.
Zissler UM, Chaker AM, Effner R, Ulrich M, Guerth F, Piontek G, Dietz K, Regn M, Knapp B, Theis FJ, Heine H, Suttner K, Schmidt-Weber CB. Zissler UM, et al. Among authors: guerth f. Mucosal Immunol. 2016 Jul;9(4):917-26. doi: 10.1038/mi.2015.110. Epub 2015 Nov 18. Mucosal Immunol. 2016. PMID: 26577568 Free article.
Early IL-10 producing B-cells and coinciding Th/Tr17 shifts during three year grass-pollen AIT.
Zissler UM, Jakwerth CA, Guerth FM, Pechtold L, Aguilar-Pimentel JA, Dietz K, Suttner K, Piontek G, Haller B, Hajdu Z, Schiemann M, Schmidt-Weber CB, Chaker AM. Zissler UM, et al. Among authors: guerth fm. EBioMedicine. 2018 Oct;36:475-488. doi: 10.1016/j.ebiom.2018.09.016. Epub 2018 Oct 11. EBioMedicine. 2018. PMID: 30318182 Free PMC article.
An exhausted phenotype of TH 2 cells is primed by allergen exposure, but not reinforced by allergen-specific immunotherapy.
Wang SH, Zissler UM, Buettner M, Heine S, Heldner A, Kotz S, Pechtold L, Kau J, Plaschke M, Ullmann JT, Guerth F, Oelsner M, Alessandrini F, Blank S, Chaker AM, Schmidt-Weber CB, Jakwerth CA. Wang SH, et al. Among authors: guerth f. Allergy. 2021 Sep;76(9):2827-2839. doi: 10.1111/all.14896. Epub 2021 May 26. Allergy. 2021. PMID: 33969495
Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatin.
Schmid SC, Sathe A, Guerth F, Seitz AK, Heck MM, Maurer T, Schwarzenböck SM, Krause BJ, Schulz WA, Stoehr R, Gschwend JE, Retz M; German Bladder Cancer Network; Nawroth R. Schmid SC, et al. Among authors: guerth f. Urol Oncol. 2017 Sep;35(9):544.e1-544.e10. doi: 10.1016/j.urolonc.2017.04.015. Epub 2017 May 10. Urol Oncol. 2017. PMID: 28501564
11 results